Overview: Tryptase TestIntroduction: The Tryptase Test measures tryptase to diagnose mastocytosis, causing skin lesions or flushing. Following 2023 AAAAI guidelines, it uses biochemical methods for high specificity, supporting allergy screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected mastocytosis.
Other Names: Tryptase Assay, Mast Cell Tryptase Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Tryptase testing began in the 1980s with allergy research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures tryptase to diagnose mastocytosis, guides treatment, and evaluates patients with skin lesions or flushing.
Test Parameters: 1. Tryptase Level
Pretest Condition: Fasting for 10-12 hours required. Collect serum or plasma. Report history of skin lesions or flushing.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document skin lesions, flushing, or history of mastocytosis. Include current medications, especially antihistamines.
Consent: Written consent required, detailing the tests purpose, mastocytosis implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) to measure tryptase levels. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for mastocytosis diagnosis.
Factors Affecting Result Accuracy: Improper fasting or sample hemolysis can affect results. Acute allergic reactions may elevate levels.
Clinical Significance: Elevated tryptase confirms mastocytosis, guiding antihistamine or mast cell stabilizer therapy. Normal levels may require bone marrow biopsy.
Specialist Consultation: Consult an allergist or hematologist for result interpretation and treatment planning.
Additional Supporting Tests: Bone marrow biopsy, KIT mutation testing, or histamine levels to confirm mastocytosis diagnosis.
Test Limitations: Non-specific in acute allergic reactions; clinical correlation is needed. Sample quality affects sensitivity.
References: AAAAI Mastocytosis Guidelines, 2023; Journal of Allergy and Clinical Immunology, Valent P, 2022.
